• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COX-2、NF-κB 及血常规指标在恶性腹膜间皮瘤预后评估中的价值。

The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma.

机构信息

Department of Gastroenterology, Cangzhou Central Hospital, Cangzhou, China.

Department of Gastroenterology, Cangzhou Central Hospital, Cangzhou, China,

出版信息

Oncol Res Treat. 2019;42(6):334-341. doi: 10.1159/000499677. Epub 2019 May 7.

DOI:10.1159/000499677
PMID:31063993
Abstract

BACKGROUND/AIMS: To investigate differences in blood routine indexes and the expression of cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-κB) in malignant peritoneal mesothelioma (MPeM) and their relationship with clinical prognosis.

METHODS

We investigated changes in blood routine indexes between the MPeM patients and healthy subjects and detected the expression of COX-2 and NF-κB in peritoneal tissues by a streptavidin-peroxidase immunohistochemistry method. Potential prognostic factors were analyzed including age, gender, white blood cell count (WBC), absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute platelet count (APC), absolute monocyte count (AMC), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), COX-2, and NF-κB. Cox regression model analysis established independent factors for the survival prognosis of the patients.

RESULTS

Compared with the control group, AMC, MXD%, ANC, neutrophilic granulocyte percentage (NEUT%), APC, NLR, MLR, and PLR were markedly increased (p < 0.05) in the MPeM group. The positivity rates for COX-2 and NF-κB expression were 59.4 and 44.9%, respectively. Single factor analyses indicated that PLR, NLR, MLR, COX-2, and NF-κB were factors that affected the overall survival of MPeM patients, but multivariate analyses identified MLR and COX-2 as independent prognostic factors.

CONCLUSIONS

High blood levels of MLR and COX-2 are adverse prognostic factors for patients with MPeM.

摘要

背景/目的:研究恶性腹膜间皮瘤(MPeM)患者血液常规指标和环氧化酶-2(COX-2)及核因子-κB(NF-κB)表达的差异及其与临床预后的关系。

方法

通过酶联免疫吸附法检测 MPeM 患者与健康受试者血液常规指标的变化,并采用链霉亲和素-过氧化物酶免疫组化法检测腹膜组织中 COX-2 和 NF-κB 的表达。分析年龄、性别、白细胞计数(WBC)、中性粒细胞绝对值(ANC)、淋巴细胞绝对值(ALC)、血小板绝对值(APC)、单核细胞绝对值(AMC)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、单核细胞与淋巴细胞比值(MLR)、COX-2 和 NF-κB 等可能的预后因素。Cox 回归模型分析确立了患者生存预后的独立因素。

结果

与对照组相比,MPeM 组的 AMC、MXD%、ANC、中性粒细胞百分比(NEUT%)、APC、NLR、MLR 和 PLR 显著升高(p<0.05)。COX-2 和 NF-κB 表达的阳性率分别为 59.4%和 44.9%。单因素分析表明,PLR、NLR、MLR、COX-2 和 NF-κB 是影响 MPeM 患者总生存的因素,但多因素分析表明 MLR 和 COX-2 是独立的预后因素。

结论

血液 MLR 和 COX-2 水平升高是 MPeM 患者不良的预后因素。

相似文献

1
The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma.COX-2、NF-κB 及血常规指标在恶性腹膜间皮瘤预后评估中的价值。
Oncol Res Treat. 2019;42(6):334-341. doi: 10.1159/000499677. Epub 2019 May 7.
2
Analysis of prognostic factors of patients with malignant peritoneal mesothelioma.恶性腹膜间皮瘤患者预后因素分析。
World J Surg Oncol. 2018 Mar 5;16(1):44. doi: 10.1186/s12957-018-1350-5.
3
Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.术前中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和单核细胞与淋巴细胞比值的联合:子宫内膜癌的一个优越预后因素。
BMC Cancer. 2020 May 24;20(1):464. doi: 10.1186/s12885-020-06953-8.
4
NLR, MLR, and PLR are adverse prognostic variables for sleeve lobectomy within non-small cell lung cancer.中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值和血小板与淋巴细胞比值是非小细胞肺癌袖状肺叶切除术的不良预后变量。
Thorac Cancer. 2024 Aug;15(24):1792-1804. doi: 10.1111/1759-7714.15405. Epub 2024 Jul 21.
5
Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值和血小板与淋巴细胞比值在第 +100 天能否作为自体移植多发性骨髓瘤患者的预后标志物?
Clin Transplant. 2018 Sep;32(9):e13359. doi: 10.1111/ctr.13359. Epub 2018 Aug 26.
6
Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma.炎症相关生物标志物对无法手术的恶性胸膜间皮瘤患者总生存期的预后影响
In Vivo. 2018 Mar-Apr;32(2):445-450. doi: 10.21873/invivo.11260.
7
Relationship between prognosis and neutrophil: lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas.恶性胸膜间皮瘤患者预后与中性粒细胞:淋巴细胞及血小板:淋巴细胞比值的关系
Asian Pac J Cancer Prev. 2014;15(5):2061-7. doi: 10.7314/apjcp.2014.15.5.2061.
8
Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort.术前中性粒细胞/白细胞比值和单核细胞/淋巴细胞比值升高预示可切除的非小细胞肺癌患者预后不良:来自大样本的结果。
Thorac Cancer. 2017 Jul;8(4):350-358. doi: 10.1111/1759-7714.12454. Epub 2017 May 22.
9
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.淋巴细胞与单核细胞比值对恶性胸膜间皮瘤患者的预后意义。
Lung Cancer. 2015 Oct;90(1):111-7. doi: 10.1016/j.lungcan.2015.07.014. Epub 2015 Jul 30.
10
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.中性粒细胞与淋巴细胞比值及单核细胞与淋巴细胞比值升高,血小板与淋巴细胞比值降低,与多发性骨髓瘤的不良预后相关。
Oncotarget. 2017 Mar 21;8(12):18792-18801. doi: 10.18632/oncotarget.13320.

引用本文的文献

1
Prognostic importance of the neutrophil-to-lymphocyte ratio in malignant peritoneal mesothelioma patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.接受肿瘤细胞减灭术和腹腔内热化疗的恶性腹膜间皮瘤患者中中性粒细胞与淋巴细胞比值的预后重要性。
BMC Cancer. 2025 Feb 14;25(1):270. doi: 10.1186/s12885-025-13606-1.
2
Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights.恶性胸膜间皮瘤免疫治疗的进展:从新兴策略到转化见解
Open Respir Arch. 2024 Apr 5;6(3):100323. doi: 10.1016/j.opresp.2024.100323. eCollection 2024 Jul-Sep.
3
Predicting survival for patients with mesothelioma: development of the PLACE prognostic model.
预测间皮瘤患者的生存率:PLACE 预后模型的建立。
BMC Cancer. 2023 Jul 26;23(1):698. doi: 10.1186/s12885-023-11180-y.
4
Prognostic significance of inflammation-related and electrolyte laboratory variables in patients with malignant pleural mesothelioma.炎症相关及电解质实验室指标在恶性胸膜间皮瘤患者中的预后意义
Front Med (Lausanne). 2023 Apr 5;10:1099685. doi: 10.3389/fmed.2023.1099685. eCollection 2023.
5
Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的临床、实验室、组织学、影像学和代谢特征及预后
Medicina (Kaunas). 2022 Dec 19;58(12):1874. doi: 10.3390/medicina58121874.
6
First study on the immunohistochemical expression of cyclooxygenase-2 and clinicopathological association in canine hepatoid gland neoplasms.犬类肝样腺肿瘤中环氧合酶-2免疫组化表达及其临床病理相关性的首次研究。
Vet World. 2022 Oct;15(10):2432-2441. doi: 10.14202/vetworld.2022.2432-2441. Epub 2022 Oct 20.
7
Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.恶性胸膜间皮瘤的生物标志物——关于炎症的新观点
Cancers (Basel). 2021 Feb 6;13(4):658. doi: 10.3390/cancers13040658.